insights_auto
Nega ANW tushdi 10,26%?
Batafsil oʻrganishchevron_right
ANW:FRA
Immuron Ltd
0,018 €
arrow_downward
-10,26%(-0,0020) 1K
14-okt, 8:12:55 (GMT+2) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoANW tikeri uchun statistika yaratilmoqda...
Ochish
0,02 €
Yuqori
0,02 €
Past
0,02 €
Bozor kapitali
9,44Â mln
Oʻrtacha hajm
904,00
Hajmi
0,00
52 haftalik eng yuqori
0,04 €
52 haftalik eng past
0,01 €
Xodimlar soni
8
Ochish
0,02 €
Yuqori
0,02 €
Past
0,02 €
Bozor kapitali
9,44Â mln
Oʻrtacha hajm
904,00
Hajmi
0,00
52 haftalik eng yuqori
0,04 €
52 haftalik eng past
0,01 €
Xodimlar soni
8
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Stock Titan
·
1 kun oldin
A travel-diarrhea pill showed 50% less severe diarrhea, but missed its main trial goals
TipRanks
·
1 kun oldin
Immuron advances Travelan after Phase 2 data published in Nature journal
Profil
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
Immuron Ltd haqida
CEO-
Xodimlar soni8
Asos solingan1994
Bosh ofislarBlackburn North, Victoria, Avstraliya
Sektor-
Veb-saytimmuron.com.au